Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023011880> ?p ?o ?g. }
- W2023011880 endingPage "1460" @default.
- W2023011880 startingPage "1451" @default.
- W2023011880 abstract "TMPRSS2:ERG gene fusions and PTEN deletions are the most common genomic aberrations in prostate cancer. Recent work has suggested that the TMPRSS2:ERG fusion is associated with a more aggressive phenotype. Similarly, PTEN deletion has been associated with biochemical recurrence and lymph node metastasis. To date, there has been no systematic analysis of the combined influence of genomic PTEN deletion with TMPRSS2:ERG gene fusions on clinical parameters of prostate cancer progression. We carried out a retrospective analysis of 125 prostate cancers with known clinical outcome using interphase fluorescence in situ hybridization to detect the relative prevalence of TMPRSS2:ERG rearrangements and/or PTEN genomic deletions. TMPRSS2:ERG rearrangement was found in 60 of 125 (48%) prostate cancers. Duplication of TMPRSS2:ERG fusion was observed in seven (6%) tumors. Gleason grade (P=0.0002)/score (P=0.001), median tumor volume (P=0.0024), preoperative PSA (P=0.001) and perineural invasion (P=0.0304) were significantly associated with biochemical recurrence by univariate analysis with TMPRSS2:ERG approaching significance (P=0.0523). By multivariate analysis, relevant factors associated with recurrence were Gleason scores 7 (P=0.001) and 8-10 (P=0.015), PTEN homozygous deletion (P=0.013) and concurrent TMPRSS2:ERG fusion and PTEN deletion (P=0.036). Kaplan-Meier analysis indicated that the presence of TMPRSS2:ERG fusion was marginally less favorable in comparison to no fusion. Duplication of fusion gene showed worse prognosis. It was possible to determine the relative frequencies of PTEN deletion and/or TMPRSS2:ERG fusions in 82 of 125 prostate cancers. With biochemical recurrence as an endpoint, the genomic biomarkers identified three patient groups: (1) 'poor genomic grade' characterized by both PTEN deletion and TMPRSS2:ERG fusions (23/82, 28%); (2) 'intermediate genomic grade' with either PTEN deletion or TMPRSS2:ERG fusion (35/82, 43%) and (3) 'favorable genomic grade' in which neither rearrangement was present (24/82, 29%). Kaplan-Meier and multivariate analysis indicate that TMPRSS2:ERG fusion and PTEN loss together are a predictor of earlier biochemical recurrence of disease." @default.
- W2023011880 created "2016-06-24" @default.
- W2023011880 creator A5002012730 @default.
- W2023011880 creator A5002265279 @default.
- W2023011880 creator A5004696064 @default.
- W2023011880 creator A5009581010 @default.
- W2023011880 creator A5039186116 @default.
- W2023011880 creator A5048719369 @default.
- W2023011880 creator A5084270604 @default.
- W2023011880 creator A5084997825 @default.
- W2023011880 creator A5085333470 @default.
- W2023011880 date "2008-12-01" @default.
- W2023011880 modified "2023-10-06" @default.
- W2023011880 title "Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome" @default.
- W2023011880 cites W1861712070 @default.
- W2023011880 cites W1964684370 @default.
- W2023011880 cites W1967279903 @default.
- W2023011880 cites W1969120957 @default.
- W2023011880 cites W1971081363 @default.
- W2023011880 cites W1972092574 @default.
- W2023011880 cites W1973206059 @default.
- W2023011880 cites W1973890143 @default.
- W2023011880 cites W1975678399 @default.
- W2023011880 cites W1976137605 @default.
- W2023011880 cites W1986927943 @default.
- W2023011880 cites W1992079095 @default.
- W2023011880 cites W1997364375 @default.
- W2023011880 cites W2006944218 @default.
- W2023011880 cites W2009775095 @default.
- W2023011880 cites W2013555459 @default.
- W2023011880 cites W2016371780 @default.
- W2023011880 cites W2018560195 @default.
- W2023011880 cites W2022408230 @default.
- W2023011880 cites W2024306318 @default.
- W2023011880 cites W2024399113 @default.
- W2023011880 cites W2031264891 @default.
- W2023011880 cites W2041002214 @default.
- W2023011880 cites W2044505245 @default.
- W2023011880 cites W2061891797 @default.
- W2023011880 cites W2070474626 @default.
- W2023011880 cites W2082462837 @default.
- W2023011880 cites W2082668371 @default.
- W2023011880 cites W2085058707 @default.
- W2023011880 cites W2093313503 @default.
- W2023011880 cites W2096800294 @default.
- W2023011880 cites W2097767970 @default.
- W2023011880 cites W2103555733 @default.
- W2023011880 cites W2113962581 @default.
- W2023011880 cites W2117936087 @default.
- W2023011880 cites W2117996979 @default.
- W2023011880 cites W2121158863 @default.
- W2023011880 cites W2129129118 @default.
- W2023011880 cites W2129583552 @default.
- W2023011880 cites W2137035181 @default.
- W2023011880 cites W2146794620 @default.
- W2023011880 cites W2149307190 @default.
- W2023011880 cites W2164895949 @default.
- W2023011880 cites W2171825914 @default.
- W2023011880 cites W2408089991 @default.
- W2023011880 doi "https://doi.org/10.1038/modpathol.2008.96" @default.
- W2023011880 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18500259" @default.
- W2023011880 hasPublicationYear "2008" @default.
- W2023011880 type Work @default.
- W2023011880 sameAs 2023011880 @default.
- W2023011880 citedByCount "256" @default.
- W2023011880 countsByYear W20230118802012 @default.
- W2023011880 countsByYear W20230118802013 @default.
- W2023011880 countsByYear W20230118802014 @default.
- W2023011880 countsByYear W20230118802015 @default.
- W2023011880 countsByYear W20230118802016 @default.
- W2023011880 countsByYear W20230118802017 @default.
- W2023011880 countsByYear W20230118802018 @default.
- W2023011880 countsByYear W20230118802019 @default.
- W2023011880 countsByYear W20230118802020 @default.
- W2023011880 countsByYear W20230118802021 @default.
- W2023011880 countsByYear W20230118802022 @default.
- W2023011880 countsByYear W20230118802023 @default.
- W2023011880 crossrefType "journal-article" @default.
- W2023011880 hasAuthorship W2023011880A5002012730 @default.
- W2023011880 hasAuthorship W2023011880A5002265279 @default.
- W2023011880 hasAuthorship W2023011880A5004696064 @default.
- W2023011880 hasAuthorship W2023011880A5009581010 @default.
- W2023011880 hasAuthorship W2023011880A5039186116 @default.
- W2023011880 hasAuthorship W2023011880A5048719369 @default.
- W2023011880 hasAuthorship W2023011880A5084270604 @default.
- W2023011880 hasAuthorship W2023011880A5084997825 @default.
- W2023011880 hasAuthorship W2023011880A5085333470 @default.
- W2023011880 hasBestOaLocation W20230118801 @default.
- W2023011880 hasConcept C103796816 @default.
- W2023011880 hasConcept C104317684 @default.
- W2023011880 hasConcept C111829193 @default.
- W2023011880 hasConcept C118487528 @default.
- W2023011880 hasConcept C121608353 @default.
- W2023011880 hasConcept C126322002 @default.
- W2023011880 hasConcept C143998085 @default.
- W2023011880 hasConcept C190283241 @default.
- W2023011880 hasConcept C2776235491 @default.
- W2023011880 hasConcept C2777609662 @default.